AMARANTUS BIOSCIENCE HLDG News Headlines

AMBS 
$0.0471
*  
0.0002
0.43 %
Get AMBS Alerts
*Delayed - data as of May 1, 2015  -  Find a broker to begin trading AMBS now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Adamas' Lead Drug Targets Parkinson's Dyskinesia
2/3/2015 5:53:00 PM - Seeking Alpha


15 Biotech Names For 2015
1/5/2015 2:37:00 PM - Seeking Alpha


Why I'm Still Optimistic On LymPro And Amarantus Bio
8/6/2014 11:33:00 AM - Seeking Alpha




Why I'm Still Optimistic On LymPro And Amarantus Bio
8/6/2014 10:07:00 AM - Seeking Alpha


Behind The Promotion Of Northwest Bio
7/7/2014 10:46:00 AM - Seeking Alpha




Behind The Promotion Of Northwest Bio
7/7/2014 9:35:00 AM - Seeking Alpha


Still Several Reasons To Remain Long Amarantus
4/9/2014 9:30:00 AM - Seeking Alpha


New Cash To Help Drive Amarantus Pipeline
2/18/2014 10:13:00 AM - Seeking Alpha




Amarantus Licenses Phase 2b Ready Eltoprazine For PD-LID
1/14/2014 10:19:00 AM - Seeking Alpha




3 Approaches To Retinitis Pigmentosa
1/2/2014 10:36:00 AM - Seeking Alpha